Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial

Table 4 Overview of adverse events (safety set)

	1 Hz (n = 22)		25 Hz (n = 24)
	Number of events	Number of patients (%)	Number of events	Number of patients (%)
Treatment emergent AEs	67	17 (77.3 %)	112	19 (79.2 %)
Treatment-related AEs	39	11 (50.0 %)	76	17 (70.8 %)
Stimulation site treatment-related TEAEs	31	10 (45.5 %)	70	17 (70.8 %)
All serious AEs (including pre-treatment SAEs)	2	2 (9.1 %)	0	0
Serious treatment emergent AEs	2	2 (9.1 %)	0	0
Serious treatment-related AEs	0	0	0	0
Treatment-related AEs leading to discontinuation of study	8	4 (18.2 %)	4	1 (4.2 %)
Death	0	0	0	0

ISSN: 1129-2377